Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Tipo de estudio
Intervalo de año de publicación
1.
J Med Genet ; 44(1): 44-50, 2007 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17018562

RESUMEN

BACKGROUND: The major determinant of age of onset in Huntington's disease is the length of the causative triplet CAG repeat. Significant variance remains, however, in residual age of onset even after repeat length is factored out. Many genetic polymorphisms have previously shown evidence of association with age of onset of Huntington's disease in several different populations. OBJECTIVE: To replicate these genetic association tests in 443 affected people from a large set of kindreds from Venezuela. METHODS: Previously tested polymorphisms were analysed in the HD gene itself (HD), the GluR6 kainate glutamate receptor (GRIK2), apolipoprotein E (APOE), the transcriptional coactivator CA150 (TCERG1), the ubiquitin carboxy-terminal hydrolase L1 (UCHL1), p53 (TP53), caspase-activated DNase (DFFB), and the NR2A and NR2B glutamate receptor subunits (GRIN2A, GRIN2B). RESULTS: The GRIN2A single-nucleotide polymorphism explains a small but considerable amount of additional variance in residual age of onset in our sample. The TCERG1 microsatellite shows a trend towards association but does not reach statistical significance, perhaps because of the uninformative nature of the polymorphism caused by extreme allele frequencies. We did not replicate the genetic association of any of the other genes. CONCLUSIONS: GRIN2A and TCERG1 may show true association with residual age of onset for Huntington's disease. The most surprising negative result is for the GRIK2 (TAA)(n) polymorphism, which has previously shown association with age of onset in four independent populations with Huntington's disease. The lack of association in the Venezuelan kindreds may be due to the extremely low frequency of the key (TAA)(16) allele in this population.


Asunto(s)
Enfermedad de Huntington/epidemiología , Enfermedad de Huntington/genética , Polimorfismo de Nucleótido Simple , Receptores de N-Metil-D-Aspartato/genética , Transactivadores/genética , Edad de Inicio , Apolipoproteínas E/genética , Desoxirribonucleasas/genética , Frecuencia de los Genes , Humanos , Proteína Huntingtina , Repeticiones de Microsatélite , Proteínas del Tejido Nervioso/genética , Proteínas Nucleares/genética , Proteínas de Unión a Poli-ADP-Ribosa , Receptores de Ácido Kaínico/genética , Factores de Elongación Transcripcional , Expansión de Repetición de Trinucleótido/genética , Proteína p53 Supresora de Tumor/genética , Ubiquitina Tiolesterasa/genética , Venezuela , Receptor de Ácido Kaínico GluK2
2.
Aust Fam Physician ; 8(9): 976-81, 1979 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-496733

RESUMEN

In this progressive disability, the earliest possible intervention gives the best chances of success. The doctor is often faced with alcohol related physical problems. To recognize and confront a patient with early alcohol problems, he needs an awareness of the early behavioural as well as physical markers of excessive drinking. He requires an understanding of the reasons for the denial so often met, and the facility of openness in confronting his patient.


Asunto(s)
Alcoholismo/psicología , Negación en Psicología , Adulto , Femenino , Humanos , Estilo de Vida , Masculino , Persona de Mediana Edad , Relaciones Médico-Paciente
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...